Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Kenta Noda"'
Autor:
Junko Tanizaki, MD, PhD, Hiroaki Kuroda, MD, PhD, Toshihide Yokoyama, MD, Makoto Takahama, MD, PhD, Hiroyasu Shoda, MD, PhD, Atsushi Nakamura, MD, PhD, Yoshitaka Kitamura, MD, PhD, Nobuaki Mamesaya, MD, PhD, Yoshihisa Kadota, MD, PhD, Kenji Sawa, MD, PhD, Kyoichi Okishio, MD, PhD, Morihito Okada, MD, PhD, Chihiro Suminaka, MS, Kenta Noda, PhD, Kazuko Sakai, PhD, Yasutaka Chiba, PhD, Kazuto Nishio, MD, PhD, Kenji Chamoto, PhD, Tasuku Honjo, MD, PhD, Nobuyuki Yamamoto, MD, PhD, Kazuhiko Nakagawa, MD, PhD, Hidetoshi Hayashi, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100590- (2023)
Introduction: Perioperative treatment in NSCLC has gained marked attention with the introduction of immune checkpoint inhibitors. Such a paradigm shift has given us additional opportunities to evaluate potential biomarkers in patients with these cura
Externí odkaz:
https://doaj.org/article/3f386ee3f72d427a96a00d99cb19bacc
Autor:
Kenji Maeda, Masayuki Amano, Yukari Uemura, Kiyoto Tsuchiya, Tomoko Matsushima, Kenta Noda, Yosuke Shimizu, Asuka Fujiwara, Yuki Takamatsu, Yasuko Ichikawa, Hidehiro Nishimura, Mari Kinoshita, Shota Matsumoto, Hiroyuki Gatanaga, Kazuhisa Yoshimura, Shin-ichi Oka, Ayako Mikami, Wataru Sugiura, Toshiyuki Sato, Tomokazu Yoshida, Shinya Shimada, Hiroaki Mitsuya
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract While mRNA vaccines against SARS-CoV-2 are exceedingly effective in preventing symptomatic infection, their immune response features remain to be clarified. In the present prospective study, 225 healthy individuals in Japan, who received two
Externí odkaz:
https://doaj.org/article/afc0cc4016284319811206f3cc4de9a3
Autor:
Kenta Noda, Kouki Matsuda, Shigehiro Yagishita, Kenji Maeda, Yutaro Akiyama, Junko Terada-Hirashima, Hiromichi Matsushita, Satoshi Iwata, Kazuto Yamashita, Yusuke Atarashi, Shunsuke Watanabe, Nobuyuki Ide, Tomokazu Yoshida, Norio Ohmagari, Hiroaki Mitsuya, Akinobu Hamada
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract The quantitative range and reproducibility of current serological tests for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are not optimized. Herein, we developed a diagnostic test that detects SARS-CoV-2 IgG and IgM with high
Externí odkaz:
https://doaj.org/article/4ee0077c063d48edb7287aa6722692e4
Autor:
Hisato Kawakami, Yu Sunakawa, Eisuke Inoue, Ryo Matoba, Kenta Noda, Toshiyuki Sato, Chihiro Suminaka, Mami Yamaki, Yasuhiro Sakamoto, Ryohei Kawabata, Atsushi Ishiguro, Yusuke Akamaru, Yosuke Kito, Hiroshi Yabusaki, Jin Matsuyama, Masazumi Takahashi, Akitaka Makiyama, Hidetoshi Hayashi, Kenji Chamoto, Tasuku Honjo, Kazuhiko Nakagawa, Wataru Ichikawa, Masashi Fujii
Publikováno v:
European Journal of Cancer. 184:10-20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3ab91c9bf9a71bdb1f61d40bbca7dbc
https://doi.org/10.1016/j.ejca.2023.02.003
https://doi.org/10.1016/j.ejca.2023.02.003
Autor:
Hirofumi Ueda, Soichiro Sato, Kenta Noda, Hiroyuki Hakamata, Eunsang Kwon, Nagao Kobayashi, Hidetoshi Tokuyama
Publikováno v:
Angewandte Chemie. 135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04024e4ee9a1eb30810251edea1c2879
https://doi.org/10.1002/ange.202302404
https://doi.org/10.1002/ange.202302404
Autor:
Takehiro, Hasegawa, Takashi, Hato, Toshitsugu, Okayama, Kazuho, Ikeo, Yoshiaki, Miyamoto, Niina, Iwanaga, Kohjin, Suzuki, Maho, Yoshida, Kazuto, Yamashita, Saya, Yamashita, Eiya, Tamada, Abdullah, Khasawneh, Faith Jessica, Paran, Rieko, Oyama, Toshio, Naito, Kenta, Noda, Yoko, Tabe
Publikováno v:
European cytokine network. 33(2)
Treatment of severe and critical cases of coronavirus disease 2019 (COVID-19) is still a top priority in public health. Previously, we reported distinct Th1 cytokines related to the pathophysiology of severe COVID-19 condition. In the present study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c98b8b077edc861e4a5bacc99063f5b
https://pubmed.ncbi.nlm.nih.gov/36266985
https://pubmed.ncbi.nlm.nih.gov/36266985
Publikováno v:
Advanced Synthesis & Catalysis. 362:3583-3588
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c94f7b25ffd5e95956a51bbbda63cdb
https://doi.org/10.1002/adsc.202000663
https://doi.org/10.1002/adsc.202000663
Autor:
Yuki Takamatsu, Shota Matsumoto, Yosuke Shimizu, Masayuki Amano, Shinya Shimada, Kenji Maeda, Tomokazu Yoshida, Kiyoto Tsuchiya, Kazuhisa Yoshimura, Ayako Mikami, Yasuko Ichikawa, Wataru Sugiura, Hidehiro Nishimura, Hiroyuki Gatanaga, Kenta Noda, Asuka Fujiwara, Mari Kinoshita, Shinichi Oka, Toshiyuki Sato, Hiroaki Mitsuya, Yukari Uemura, Tomoko Matsushima
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
medRxiv
article-version (status) pre
article-version (number) 1
Scientific Reports
medRxiv
article-version (status) pre
article-version (number) 1
SUMMARYBackgroundWhile mRNA vaccines against SARS-CoV-2 have been exceedingly effective in preventing symptomatic viral infection, the features of immune response remain to be clarified.MethodsIn the present prospective observational study, 225 healt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::278a642908d1db5c9ac32790796ce0b5
https://doi.org/10.1038/s41598-021-01930-y
https://doi.org/10.1038/s41598-021-01930-y
Autor:
Saya Yamashita, Kazuto Yamashita, Takehiro Hasegawa, Eiya Tamada, Atsushi Nakagawa, Niina Iwanaga, Kenta Noda, Keisuke Tomii, Kohjin Suzuki
Publikováno v:
Cytokine
Graphical abstract
Background Coronavirus disease 2019 (COVID-19) is an acute respiratory disease; approximately 5% of patients developing severe COVID-19. It is known that cytokine release is associated with disease severity, but the relationsh
Background Coronavirus disease 2019 (COVID-19) is an acute respiratory disease; approximately 5% of patients developing severe COVID-19. It is known that cytokine release is associated with disease severity, but the relationsh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f77c8e6e57d7b09cfb608c504aca9d83
https://doi.org/10.1183/13993003.congress-2021.oa3972
https://doi.org/10.1183/13993003.congress-2021.oa3972
Publikováno v:
Chemical communications (Cambridge, England). 57(61)
We introduce readily available ammonium hemiaminals as O-transfer reagents and commercially available acetonitriles as a primary amide enolate precursor. The combination serves as an amide enolate equivalent, thereby providing one-pot access to alpha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f7d49fc4bfc55cb449f3fde96c5c63f
https://pubmed.ncbi.nlm.nih.gov/34212954
https://pubmed.ncbi.nlm.nih.gov/34212954